Filariasis Research Centre, Yaoundé, Cameroon.
Am J Trop Med Hyg. 2009 Dec;81(6):1056-61. doi: 10.4269/ajtmh.2009.09-0356.
The main risk factor of post-ivermectin serious adverse events (SAEs) is the presence of a high Loa loa microfilaremia. However, the majority of patients with such high loads do not develop SAEs, suggesting that co-factors may be involved. An infection with simian Loa parasites, whose microfilariae show a nocturnal periodicity, might be such a co-factor. The periodicity of Loa microfilariae was compared, using cosinor methodology, in 4 patients who had developed a post-ivermectin neurologic SAE, 4 patients who had experienced a non-neurologic SAE, and 14 control individuals. The periodicity was similar in all three groups, with a peak of microfilaremia occurring between 12:30 and 2:00 PM. The results of this study, which for the first time characterizes the periodicity of Loa microfilariae mathematically, suggest that post-ivermectin SAEs are not related to an infection with a Loa simian strain.
伊维菌素治疗后严重不良事件(SAEs)的主要危险因素是存在高负荷罗阿罗阿微丝蚴血症。然而,大多数存在如此高负荷的患者并未出现 SAE,这表明可能存在合并因素。感染具有夜间周期性的灵长类罗阿寄生虫可能就是这样的合并因素。使用余弦分析方法比较了 4 例发生伊维菌素治疗后神经 SAE 的患者、4 例出现非神经 SAE 的患者和 14 例对照个体的罗阿微丝蚴的周期性。所有三组的周期性相似,微丝蚴峰值出现在下午 12:30 至 2:00 之间。这项首次从数学上描述罗阿微丝蚴周期性的研究结果表明,伊维菌素治疗后 SAE 与感染灵长类罗阿寄生虫无关。